Cannabidiol, Synthetically Produced

Cannabidiol, Synthetically Produced and pregnancy

Caution Advised

• Absorbed into the body
• Fetal development

Synthetically produced cannabidiol is chemically identical to plant-derived CBD, with the same molecular structure and biological activity. While synthetic production offers better purity control, the compound itself has the same potential for skin absorption and biological effects as hemp-derived CBD. According to the FDA, pregnant women should avoid CBD products regardless of their source (plant or synthetic) due to insufficient safety data during pregnancy. ACOG's guidance on avoiding cannabis products extends to all cannabinoids, including synthetically produced ones. The theoretical concern is that CBD, being lipophilic, could cross the placental barrier if systemically absorbed, though topical absorption is significantly lower than oral intake. Animal studies showing potential fetal effects involved high oral doses, but human topical safety data is lacking. Many obstetricians recommend that pregnant women postpone all CBD use, synthetic or natural, until after delivery due to the precautionary principle. While synthetic CBD may be purer than plant extracts, the underlying compound and its potential effects remain the same. Women seeking antioxidant skincare during pregnancy have many well-studied alternatives available.

Cannabidiol, Synthetically Produced and breastfeeding

Caution Advised

• Passes into breast milk
• Infant exposure

Synthetically produced CBD has the same chemical structure as plant-derived CBD and therefore the same potential for absorption and transfer into breast milk. The fat-soluble nature of cannabidiol means that any systemically absorbed amount could theoretically accumulate in breast milk. The FDA and American Academy of Pediatrics recommend avoiding CBD during breastfeeding due to limited safety data on infant exposure. While synthetic CBD offers purity advantages over plant extracts, it does not change the fundamental concern about cannabinoid exposure during infant brain development. Topical application results in much lower systemic levels than oral consumption, but the precautionary principle applies given the lack of human studies. Most healthcare providers advise breastfeeding mothers to postpone CBD cosmetics, whether synthetic or natural, until after weaning. The advantage of synthetic CBD is consistency and purity, but this does not eliminate the concern about potential infant exposure. Mothers seeking anti-inflammatory skincare can choose from numerous well-researched alternatives with established safety profiles during lactation.

Cannabidiol, Synthetically Produced and postpartum

Safe to Use

For postpartum women who are not breastfeeding, synthetically produced CBD offers the same benefits as plant-derived CBD with potentially better purity. Its anti-inflammatory and antioxidant properties may help address postpartum skin concerns such as sensitivity, redness, or oxidative stress. Synthetic production ensures consistent potency and eliminates concerns about pesticides or contaminants that sometimes affect hemp-derived products. Postpartum women can safely use this ingredient in their skincare routine, potentially benefiting from its soothing properties during the hormonal transition period.

Cannabidiol, Synthetically Produced and trying to conceive

Safe to Use

For women trying to conceive, synthetically produced CBD carries the same minimal concerns as plant-derived CBD. There is no evidence that topical CBD use affects fertility, ovulation, or conception rates. The synthetic form may offer purity advantages that eliminate concerns about contaminants. Some women choose to discontinue all CBD products when actively trying to conceive as a precautionary measure, though this is based on theoretical concerns rather than documented risks. Topical absorption of CBD is minimal, and there is no known mechanism by which cosmetic CBD use would impact fertility. This decision is personal and should be discussed with healthcare providers.

Cannabidiol, Synthetically Produced and PCOS

Safe to Use

Synthetically produced CBD offers the same potential benefits for PCOS-related skin concerns as plant-derived CBD. Research suggests CBD may help regulate sebum production and reduce inflammation, both relevant to acne that commonly affects women with PCOS. The synthetic form provides more consistent potency, which may be advantageous for addressing specific skin concerns. CBD's anti-inflammatory mechanism works independently of hormonal pathways, so it does not interfere with PCOS-related hormone imbalances or treatments. Preliminary studies indicate CBD has antibacterial properties against acne-causing bacteria. While evidence specific to PCOS is limited, dermatologists note that CBD's anti-inflammatory properties may complement other acne treatments. Women with PCOS can safely incorporate synthetic CBD into their skincare routine. The purity advantage of synthetic CBD may reduce the risk of contamination-related breakouts compared to some plant-derived products.

Cannabidiol, Synthetically Produced and general use

Safe to Use

Synthetically produced cannabidiol offers the same topical benefits as plant-derived CBD but with advantages in purity and consistency. It functions as an antioxidant and anti-inflammatory ingredient, helping to soothe irritated skin and protect against oxidative damage. Being synthetically produced, it contains no THC or plant contaminants. For the general public, synthetic CBD has a good safety profile with minimal side effects. The controlled production process ensures consistent potency and eliminates concerns about pesticides, heavy metals, or other contaminants that can affect hemp-derived products. This makes synthetic CBD potentially safer than some plant extracts, though individual product quality still varies. Dermatological research on CBD shows promise for anti-inflammatory applications, though more clinical studies are needed. Synthetic CBD is non-psychoactive and does not cause the effects associated with THC. It is generally well-tolerated by most skin types with low risk of irritation or allergic reactions.

Everything else flagged for the same profiles

• Flagged in pregnancy
• Flagged in breastfeeding

Related ingredients

Ingredients suggested in place of Cannabidiol, Synthetically Produced, each one with its own page here.

• Niacinamide
• Azelaic Acid
• Colloidal Oatmeal
• Panthenol

Ingredients that raise the same concerns.

• Cocamide MEAFetal development, Infant exposure, Passes into breast milk
• Benzophenone-4Fetal development, Infant exposure, Passes into breast milk
• Benzophenone-3Fetal development, Infant exposure, Passes into breast milk
• ButylparabenFetal development, Infant exposure, Passes into breast milk
• CamphorFetal development, Infant exposure, Passes into breast milk
• Symphytum Officinale Leaf ExtractFetal development, Infant exposure, Passes into breast milk

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.